Figure 1
From: Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy
Three genes—EGFR, FGFR2 and MYC—overlap between genes whose array expression levels correlated with survival times (96 training set patients, P<0.05) and gene copy number changes determined by array comparative genomic hybridization (CGH) (tumor/normal log2 ratio >2 for ⩾5 consecutive probes).
